Measuring disease activity in juvenile systemic sclerosis: a multidisciplinary consensus from the Hamburg 2024 symposium
Ivan Foeldvari(Schön Klinik Hamburg Eilbek), Vanessa Smith(Ghent University Hospital), C Bruni(University of Zurich), Suzanne C. Li(Hackensack Meridian Health), Edoardo Marrani(Meyer Children's Hospital), John D Pauling(Royal National Hospital for Rheumatic Diseases), Jonathan Li(Massachusetts Institute of Technology), Catherine H. Orteu(Royal Free London NHS Foundation Trust), Patrícia Costa-Reis, Jörg Henes(University of Tübingen), Clarissa Pilkington, Kim Fligelstone(National Patient Safety Foundation), Daniel E. Furst(University of Washington), Ozgur Kasapcopur(Istanbul University-Cerrahpaşa), Laura Ross(The University of Melbourne), Christopher P. Denton(Royal Free London NHS Foundation Trust), Dieneke Schonenberg-Meinema(Amsterdam University Medical Centers), Jens Klotsche(German Rheumatism Research Centre), Clara Gimenez-Roca(Clínica Diagonal), M CUTOLO(Polyclinic Medical Center), Francesco Del Galdo(Leeds Teaching Hospitals NHS Trust), Kathryn S. Torok(University of Pittsburgh Medical Center)
Cited by 0
Related Papers
Mapping and predicting mortality from systemic sclerosis
|Annals of the Rheumatic Diseases|2017|699
European Dermatology Forum S1‐guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: localized scleroderma, systemic sclerosis and overlap syndromes
|Journal of the European Academy of Dermatology and Venereology|2017|262
Distinct interferon signatures and cytokine patterns define additional systemic autoinflammatory diseases
|Journal of Clinical Investigation|2019|240
Interferon‐β mediates stromal cell rescue of T cells from apoptosis
|European Journal of Immunology|1999|199
Fabry disease and the skin: data from FOS, the Fabry outcome survey
|British Journal of Dermatology|2007|178